Canadian venture group Tilting Capital said last week that it’s planning a reverse merger with Golden, Colo.-based ophthalmic imaging device developer ArcScan. Tilting Capital said it agreed to put up about $7.2 million (Cdn $9.2 million) worth of its own stock, or 61.4 million shares, valued at 12¢ (Cdn 15¢) apiece, in a 1-for-1 trade with ArcScan stockowners. The […]